Priority Date: 16.12.11 (US 201161576835P)

PROGRAMMABLE CELL MODEL FOR DETERMINING CANCER TREATMENTS

  • Application ID: EP12856939
  • Status: GRANT OF PATENT INTENDED

Attorney

Employment test 11 - 50 employees
Company dna graf gluck kritzenberger
no operation time available
Headquarter in Regensburg and 1 office
active in Legal Services, IP Consulting, and IP Portfolio Processing

Specialization

This EP application has the IPC combination C12 (BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING) and G06 (COMPUTING; CALCULATING; COUNTING). We found, that D Young & Co LLP, Kilburn & Strode LLP, IP Asset LLP, Keltie LLP, Santarelli and 26 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 16.12.2011 - Priority Date (US 201161576835P)
  • 20.06.2013 - Publication A1 (WO2013086619)
  • 22.10.2014 - Publication A1 (EP2791843)

IPC Classification